Volume 11, Issue 2 ( June 2019 2019)                   Iranian Journal of Blood and Cancer 2019, 11(2): 47-50 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ferdowsi S, Najafzadeh M, Ameli M R, Sajjadi S M. Evaluating the Frequency of Human T-Lymphotropic Virus Type 1 Infection in Iranian Population. Iranian Journal of Blood and Cancer 2019; 11 (2) :47-50
URL: http://ijbc.ir/article-1-866-en.html
1- 1. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine,
2- Birjand University of medical sciences, Birjand, Iran
3- Blood Transfusion Research Center, South Khorasan Regional Transfusion Center, Birjand, Iran
4- Cellular and molecular research center, Birjand university o medical sciences , ferdowsishirin@gmail.com
Abstract:   (3745 Views)

Background: Human T-cell lymphotropic viruses 1 (HTLV1) is endemic in specific regions. We aimed to determine the prevalence of HTLV I infection among blood donors in southeast Iran.  
Methods: This cross-sectional study was conducted between April 2005 and March 2015. Sera were collected from blood donors and were tested for the presence of HTLV1 specific antibody using ELISA. Reactive samples were then tested by Western blot for confirmation.
Results: Of the 165,267 blood donors tested for HTLV 1 antibody, 45 (0.027%) donors were positive. Out of 45 positive donors, 41 were first time blood donors, 3 were repeat blood donors and 1 as regular donor. Most HTLV-1-positive donors were male and married. Co-infection with HBV was observed in one subject. The percentage of positive samples had increasing patterns from 0.016% in 2009 to 0.084% in 2010 and decreased after that to 0.014% in 2015.
Conclusion: The results indicated a low level of infection of HTLV1 in this part of our country. 

Full-Text [PDF 443 kb]   (1374 Downloads)    
: Original Article | Subject: Infectious Diseases
Received: 2018/12/22 | Accepted: 2019/08/17 | Published: 2019/08/17

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb